» Articles » PMID: 20951944

Myeloid Leukemia Development in C-Cbl RING Finger Mutant Mice is Dependent on FLT3 Signaling

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2010 Oct 19
PMID 20951944
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Although myeloid leukemias are primarily caused by leukemic stem cells, the molecular basis of their transformation remains largely unknown. Here, by analyzing mice with a mutation in the RING finger domain of c-Cbl, we show that the E3 ubiquitin ligase activity of c-Cbl is required to restrict myeloid leukemia development. These mice develop a myeloproliferative disease which progresses to leukemia and involves hematopoietic progenitors that exhibit augmented FLT3 signaling. Suppressing this signaling through matings with FLT3 ligand knockout mice prevents leukemia development. We also observe enhanced c-Kit, Akt and Erk activity, and deregulated expression of leukemia-associated transcription factors in hematopoietic progenitors. The characterization of these perturbations provides direction for therapeutics that may aid the treatment of patients with c-Cbl mutations.

Citing Articles

Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia.

Fu S, Guo Y, Peng Z, Zhang D, Chang Z, Xiao Y Med Oncol. 2024; 42(1):25.

PMID: 39652257 PMC: 11628578. DOI: 10.1007/s12032-024-02549-5.


LNK/SH2B3 Loss Exacerbates the Development of Myeloproliferative Neoplasms in CBL-deficient Mice.

Chen Y, Gong S, Tang J, Wang X, Gao Y, Yang H Stem Cell Rev Rep. 2024; 21(2):509-519.

PMID: 39560864 DOI: 10.1007/s12015-024-10825-0.


The E3 ligase TRIM31 regulates hematopoietic stem cell homeostasis and MLL-AF9 leukemia.

Zhang K, Liu D, Li Y, Shi Z, Guo J, Gao C Haematologica. 2023; 108(8):2116-2129.

PMID: 36632737 PMC: 10388288. DOI: 10.3324/haematol.2022.281955.


E3 ubiquitin ligases in the acute leukemic signaling pathways.

Zhan Q, Zhang H, Wu B, Zhang N, Zhang L Front Physiol. 2022; 13:1004330.

PMID: 36439256 PMC: 9691902. DOI: 10.3389/fphys.2022.1004330.


PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371.

Chen H, Bai Y, Kobayashi M, Xiao S, Cai W, Barajas S Blood. 2022; 141(3):244-259.

PMID: 36206490 PMC: 9936309. DOI: 10.1182/blood.2022016580.